Log in
Enquire now
VBI Vaccines Inc.

VBI Vaccines Inc.

A biopharmaceutical company with a focus on developing and manufacturing vaccines. It was founded in 2001 and has headquarters in Cambridge, Massachusetts.

OverviewStructured DataIssuesContributors

Contents

vbivaccines.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Engineering
Engineering
Biopharmaceutical
Biopharmaceutical
Vaccine
Vaccine
Biomedical engineering
Biomedical engineering
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
...
Location
United States
United States
Cambridge, Massachusetts
Cambridge, Massachusetts
0
Canada
Canada
B2X
B2B
B2B
0
B2C
B2C
Founder
‌
David Anderson
Pitchbook URL
pitchbook.com/profiles.../52513-93
Legal Name
VBI Vaccines Inc.0
Legal classification
Public company
Public company
0
Number of Employees (Ranges)
51 – 200
Email Address
info@vbivaccines.com0
Phone Number
+161783030310
Number of Employees
1490
Full Address
160 Second Street, Floor 3 Cambridge, MA 02142, USA0
222 Third Street, Suite 2241 Cambridge, MA 02142
CIK Number
704,1590
Place of Incorporation
Delaware
Delaware
0
Investors
OPKO Health
OPKO Health
Pontifax Venture Capital
Pontifax Venture Capital
K2 HealthVentures
K2 HealthVentures
ARCH Venture Partners
ARCH Venture Partners
Perceptive Advisors
Perceptive Advisors
IRS Number
930,589,5340
Founded Date
2001
Total Funding Amount (USD)
163,701,100
Latest Funding Round Date
May 27, 2020
Business Model
Commerce
Stock Symbol
VBIV0
Exchange
Nasdaq
Nasdaq
0
Board of Directors
‌
Steven Gillis
0
‌
Blaine McKee
0
Linda C. Bain
Linda C. Bain
0
Latest Funding Type
Private equity
Private equity
Country
United States
United States
0

Other attributes

Company Operating Status
Active
Previous Name
PAULSON CAPITAL (DELAWARE) CORP.0
PAULSON CAPITAL CORP0
SIC Code
2,8360
Ticker Symbol
VBIV0

VBI Vaccines Inc. is a Massachusetts-based company specializing in the development and production of vaccines for infectious diseases. It has already developed a vaccine for Hepatitis B, which is available in Israel and is in the process of being approved in the United States.

COVID-19

During the COVID-19 pandemic, the company utilized a sub-unit approach when developing a vaccine for the virus. It has partnered with the National Research Council of Canada in order to continue its rsearch and testing .

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

It is 'kind of a proven technology': Hep B vaccine maker joins global hunt for coronavirus vaccine

Natalie Grover

https://endpts.com/it-is-kind-of-a-proven-technology-hep-b-vaccine-maker-joins-global-hunt-for-coronavirus-vaccine/

Web

March 31, 2020

VBI Vaccines Announces Collaboration with the National Research Council of Canada to Develop Pan-Coronavirus Vaccine Candidate Targeting COVID-19, SARS, and MERS

https://finance.yahoo.com/news/vbi-vaccines-announces-collaboration-national-120000828.html

Web

March 31, 2020

References

Find more companies like VBI Vaccines Inc.

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.